Growth Hormone & Igf Research

Papers
(The TQCC of Growth Hormone & Igf Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Impact of short stature on quality of life: A systematic literature review30
Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology25
The effect of combined functional training on BDNF, IGF-1, and their association with health-related fitness in the multiple sclerosis women16
Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology16
Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism?11
Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity10
Economic and clinical burden of comorbidities among patients with acromegaly10
The IGF system and longitudinal growth in preterm infants in relation to gestational age, birth weight and gender10
Digital technologies to improve the precision of paediatric growth disorder diagnosis and management9
Effects of a home-based exercise program on the insulin-like growth factor axis in patients operated for colorectal cancer in Sweden: Results from the randomised controlled trial PHYSSURG-C9
Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study9
Molecular and cellular effects of insulin-like growth factor-1 and LongR3-IGF-1 on in vitro maturation of bovine oocytes: comparative study9
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis8
Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services8
Mechanisms of putative IGF-I receptor resistance in active acromegaly8
Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observa8
The combined frequencies of the IL-6 G-174C and IGFBP3 A-202C polymorphisms among swimmers and runners7
Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly7
Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children7
Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in p7
Potential applications for rhIGF-I: Bone disease and IGF I7
Tissue-specific disruption of the growth hormone receptor (GHR) in mice: An update7
Hormonal stress responses of growth hormone and insulin-like growth factor-I in highly resistance trained women and men7
A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury6
Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas6
Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency6
The association between treatment and systemic inflammation in acromegaly6
Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue6
Linkage between growth retardation and pituitary cell morphology in a dystrophin-deficient pig model of Duchenne muscular dystrophy6
Endoplasmic reticulum stress induces growth retardation by inhibiting growth hormone IGF-I axis6
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis6
Analyzing structural differences between insulin receptor (IR) and IGF1R for designing small molecule allosteric inhibitors of IGF1R as novel anti-cancer agents5
Childhood growth hormone deficiency, a diagnosis in evolution: The intersection of growth hormone history and ethics5
Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats5
Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases5
Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients5
Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center5
Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature4
Growth hormone secreting pituitary carcinomas: Case report and review of literature4
Dental arches in inherited severe isolated growth hormone deficiency4
The effect of milk and rapeseed protein on growth factors in 7–8 year-old healthy children – A randomized controlled trial4
The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytes4
Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study4
Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency4
0.021356821060181